Desoximetasone Ointment USP, 0.25%, a) 15 g tubes (NDC 61748-206-15 and b) 60 g tubes (NDC 61748-206-60, Marketed by Versapharm Inc., An Akorn Company, Lake Forest, IL, Manufactured by Hi-Tech, Pharmacal Co, Inc., Amityville, NY
Published November 30, 2016 · Recall initiated: November 14, 2016
Summary
FDA records drug Class II recall D-0152-2017, published November 30, 2016 and initiated November 14, 2016. Recalling firm: Akorn Inc; Status: Terminated; Reported quantity: a) 62 tubes and b) 91 tubes; Lot: Lot #348716 (exp. 12/2017). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Stability Specifications; out-of specification value for homogeneity / phase separation.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Akorn Inc
- Distributor
- Nationwide
- Lot
- Lot #348716 (exp. 12/2017)
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFentanyl Citrate Injection, USP, 100 mcg/2 mL (50 mcg/mL), 10 Ampules per carton, (2 mL each), Rx only,April 8, 2020
- FDAHydrocortisone and Acetic Acid Otic Solution, USP, 10 mL dropper bottle, Rx only, HI-TECH PHARMACAL CO., INC.,February 19, 2020
- FDAMyorisan (isotretinoin capsules, USP), 40 mg, packaged in cartons of 30 Capsules containing 3 x 10June 26, 2019
- FDAHydrocortisone and Acetic Acid Otic Solution, USP, 10 mL per dropper bottle, Rx only, Hi-Tech Pharmacal Co,March 27, 2019
- FDADiltiazem HCl Extended-release Capsules, USP 120 mg, 100-count bottle (NDC 0378-5220-01), 500-count bottleNovember 30, 2016
- FDAFentanyl Citrate Injection, USP, 100 mcg Fentanyl/ 2mL, Single Dose, 50 mcg/mL, Rx only, Hospira, Inc., LakeNovember 30, 2016
Questions about this recall
Was Desoximetasone Ointment USP, 0.25%, a) 15 g tubes (NDC 61748-206-15 and b) 60 g tubes (NDC 61748-206-60, Marketed by Versapharm Inc., An Akorn Company, Lake Forest, IL, Manufactured by Hi-Tech, Pharmacal Co, Inc., Amityville, NY recalled?
Yes. FDA published recall D-0152-2017 on November 30, 2016. Reported hazard: Failed Stability Specifications; out-of specification value for homogeneity / phase separation.
What should I do if I have this product?
Voluntary: Firm initiated · Letter